These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15019336)

  • 21. Two discrete uveal melanomas in a child with ocular melanocytosis.
    Shields CL; Eagle RC; Ip MS; Marr BP; Shields JA
    Retina; 2006; 26(6):684-7. PubMed ID: 16829813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
    Seregard S; Oskarsson M; Spångberg B
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultrasound monitoring of the course of uveal melanoma].
    Kat'kova EA
    Vestn Oftalmol; 2006; 122(4):3-6. PubMed ID: 16927772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of high-frequency ultrasound backscatter with tumor microstructure in iris melanoma.
    Ursea R; Coleman DJ; Silverman RH; Lizzi FL; Daly SM; Harrison W
    Ophthalmology; 1998 May; 105(5):906-12. PubMed ID: 9593396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uveal melanoma: detection of extraocular growth with MR imaging and US.
    Hosten N; Bornfeld N; Wassmuth R; Lemke AJ; Sander B; Bechrakis NE; Felix R
    Radiology; 1997 Jan; 202(1):61-7. PubMed ID: 8988193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ring melanoma].
    Szuścik I; Romanowska-Dixon B; Jakubowska B; Orłowska-Heitzman J
    Klin Oczna; 2008; 110(10-12):375-9. PubMed ID: 19195170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma.
    Zaks O; Gaber D; Ben-Yaakov K; Sharvit-Bader M; Goz A; Rotfogel Z; Ish-Shalom S; Kesler E; Yosepovich A; Leiba H; Jager MJ; Marcovich AL; Aharoni-Simon M
    Exp Eye Res; 2021 Mar; 204():108431. PubMed ID: 33406396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of morphometric features and the callender classification in uveal melanomas.
    Coleman K; Baak JP; van Diest PJ; Mullaney J
    Ophthalmology; 1996 Oct; 103(10):1634-41. PubMed ID: 8874437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations.
    Zhang Q; Yang H; Kang SJ; Wang Y; Wang GD; Coulthard T; Grossniklaus HE
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2662-8. PubMed ID: 21245408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Cytologic Features of Uveal Melanoma.
    Medina CA; Biscotti CV; Singh N; Singh AD
    Ophthalmology; 2015 Aug; 122(8):1580-4. PubMed ID: 26012864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning.
    Beenakker JW; Ferreira TA; Soemarwoto KP; Genders SW; Teeuwisse WM; Webb AG; Luyten GP
    MAGMA; 2016 Jun; 29(3):571-7. PubMed ID: 26915081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study.
    Folberg R; Pe'er J; Gruman LM; Woolson RF; Jeng G; Montague PR; Moninger TO; Yi H; Moore KC
    Hum Pathol; 1992 Nov; 23(11):1298-305. PubMed ID: 1427757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation].
    Kantelip B; Albuisson E; Bacin F; Bonhomme R
    Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
    Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
    Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed cell malignant melanoma of the ciliary body.
    Karim MM; Inoue M; Ohbayashi C; Ito H
    Kobe J Med Sci; 1995 Oct; 41(5):155-66. PubMed ID: 8929636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma.
    Al-Jamal RT; Kivelä T
    Can J Ophthalmol; 2011 Dec; 46(6):471-6. PubMed ID: 22153631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.